Rhineland Bio: Four executives plan to reduce their shareholding by 0.14%

Rhineland Biological Announcement: Chairman and General Manager Xie Yongfu, Director and Deputy General Manager Bai Yu, Director and Deputy General Manager and Chief Financial Officer Zheng Hui, Deputy General Manager and Corporate Secretary Luo Huayang plan to reduce their holdings of a total of 1,018,500 shares, accounting for 0.14% of the total share capital of the company through centralized bidding within 3 months after 15 trading days from the date of this announcement for personal financial needs. The divestment price will be determined based on the market price.